Protembis is a medical device start-up company headquartered in the engineering and technology city of Aachen, Germany. The company’s vision is to bring the ProtEmbo® System into every interventional heart procedure to minimize the risk of embolic cerebral lesions and to prevent substantial neurologic injury, thereby radically improving patient safety. Protembis is sponsored by the Federal Ministry of Education and Research as well as by a consortium of experienced private and institutional Investors.
For more details please visit www.protembis.com.